Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Cash Flows

v3.22.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 354,108 $ 108,013 $ 330,489
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, Amortization And Non-Cash Lease Expense 115,571 146,601 121,725
Accounts Receivable, Credit Loss Expense (Reversal) (10,758) 19,156 (108)
Gain (Loss) on Disposition of Assets (1,233) (31,342) (5,442)
Deferred income taxes (9,798) (11,263) (1,808)
Share-based Payment Arrangement, Noncash Expense 19,126 17,778 17,832
Changes in operating assets and liabilities:      
Increase (Decrease) in Accounts Receivable (31,622) 22,885 (37,429)
Increase (Decrease) in Inventories (100,261) 64,884 (84,058)
Increase (Decrease) in Prepaid Expense and Other Assets (24,858) 33,712 (15,068)
Increase (Decrease) in Prepaid Expense and Other Assets 24,858 (33,712) 15,068
Increase (Decrease) in Other Noncurrent Assets (1,231) 21,224 3,547
Increase (Decrease) in Accounts Payable 75,513 (49,275) (10,419)
Increase (Decrease) in Accrued Liabilities 66,457 (52,115) 18,863
Increase (Decrease) in Income Taxes Payable (15,248) 9,082 (9,402)
Increase (Decrease) in Other Operating Assets and Liabilities, Net 85,176 52,112 54,197
Increase (Decrease) in Other Noncurrent Liabilities (1,112) 8,613 7,137
Net cash provided by operating activities 354,406 276,077 285,452
Cash flows from investing activities:      
Payments to Acquire Short-term Investments (130,191) (35,044) (136,257)
Proceeds from Sale, Maturity and Collection of Short-term Investments 1,184 36,631 400,501
Payments to Acquire Productive Assets 34,744 28,758 123,516
Net cash used in investing activities (163,751) (27,171) 140,728
Cash flows from financing activities:      
Proceeds from Lines of Credit 38,334 402,422 78,186
Repayments of Lines of Credit (38,156) (403,146) (78,186)
Debt Issuance Costs, Line of Credit Arrangements, Gross 0 (3,278) 0
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 28,783 6,919 19,793
Payment, Tax Withholding, Share-based Payment Arrangement (5,812) (4,533) (5,806)
Payments for Repurchase of Common Stock (165,415) (132,889) (121,702)
Payments to Noncontrolling Interests 0 0 17,880
Payments of Dividends 68,623 17,195 65,127
Net cash used in financing activities (210,889) (151,700) (190,722)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (27,321) 104,716 234,214
Effect of Exchange Rate on Cash (7,087) 7,510 (1,244)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance 790,725 686,009  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 763,404 790,725 686,009
Supplemental disclosures of cash flow information:      
Income Taxes Paid 129,483 14,687 99,062
Supplemental disclosures of non-cash investing activities:      
Capital expenditures incurred but not yet paid $ 5,853 $ 3,831 $ 9,543